BCL2L11 and acute myeloid leukemia: The levels of these two genes were balanced in ctrl or shifted towards the pro-apoptotic BCL2L11. On the contrary, in the majority of the AML samples, including all from the X subgroup, the pro-apoptotic BCL2 evidently predominated (Figure 2C).